Home / Share Price Target / Sparc
Sun Pharma Advanced Research Company Share Price Target 2024, 2025, 2026 to 2039 With Charts
Sun Pharma Advanced Research Company Limited | |||
 | Symbol: SPARC | ||
| Price: ₹226.66 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers - Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Sun Pharma Advanced Research Company Brief Company Overview
- 1.1: Overview of Sun Pharma Advanced Research Company Limited
- 1.1.1: Notable Products
- 1.1.2: Development Pipeline
- 1.2: Sun Pharma Advanced Research Company Financial Performance
- 1.2.1: Is Sun Pharma Advanced Research Company A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Sun Pharma Advanced Research Company Share Price Target For 2024
- 2.1.1: Sun Pharma Advanced Research Company Share Price Target Table For 2024
- 2.1.2: Summary: Sun Pharma Advanced Research Company Share Price Prediction For 2024
- 2.2: Sun Pharma Advanced Research Company Share Price Target For 2025
- 2.2.1: Sun Pharma Advanced Research Company Share Price Target Table For 2025
- 2.2.2: Summary: Sun Pharma Advanced Research Company Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Sun Pharma Advanced Research Company Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Sun Pharma Advanced Research Company Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Sun Pharma Advanced Research Company Past Performance
Sun Pharma Advanced Research Company Brief Company Overview
Overview of Sun Pharma Advanced Research Company Limited
Sun Pharma Advanced Research Company Limited is a leading biopharmaceutical company dedicated to research and development of innovative pharmaceutical products. Founded in 2006 and headquartered in Mumbai, India, the company has a strong presence in India and internationally.
Sun Pharma Advanced Research is renowned for its diverse product portfolio, with a focus on therapeutics for oncology, neurodegeneration, ophthalmology, dermatology, and immunology.
Notable Products
- Elepsia XR (anti-epileptic)
- Xelpros (glaucoma treatment)
- Phenobarbital injection (neonatal seizures)
Development Pipeline
The company is committed to expanding its product range through ongoing research and development. Some key pipeline candidates include:
- SDN-037 (ocular surgery inflammation)
- PDP-716 (glaucoma)
- Vodobatinib (chronic myelogenous leukemia and Parkinson's disease)
- SCD-044 (psoriasis and atopic dermatitis)
- SCO-120 (breast cancer)
Advertisement
Sun Pharma Advanced Research Company Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 7,019.41 Crore | Market valuation of Sun Pharma Advanced Research Company's shares. |
| Revenue (TTM) | 106.68 Crore | Total revenue generated by Sun Pharma Advanced Research Company over the past twelve months. |
| Net Income (TTM) | -363.41 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | -763.21% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 28.14% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | -89.4% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio | 4.28 | Company's total debt divided by total shareholder equity. |
| Total Debt | 14.21 Crore | Sum of Sun Pharma Advanced Research Company's current & long-term financial obligations. |
| Total Cash | 366.09 Crore | Total amount of liquid funds available to Sun Pharma Advanced Research Company. |
| Beta | 0.74 | Beta is less than 1 indicating that the Sun Pharma Advanced Research Company's price is less volatile than the market. |
Is Sun Pharma Advanced Research Company A Good Buy For Long Term?
Despite a recent revenue decline and a negative profit margin, Sun Pharma Advanced Research Company has historically delivered positive returns over the long term. With a revenue of 106.68 Crore, a net profit of -363.41 Crore, and a market cap of 7,257.93 Crore, the company's financials warrant caution. Its recent -89.4% revenue change compared to the previous quarter raises concerns. However, its past performance suggests potential for long-term growth.
To predict the Sun Pharma Advanced Research Company's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Sun Pharma Advanced Research Company Share Price Target For 2024
The line chart displays the monthly closing prices of Sun Pharma Advanced Research Company with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Sun Pharma Advanced Research Company shares in 2024, see the table below.
Advertisement
Sun Pharma Advanced Research Company Share Price Target Table For 2024
| Sun Pharma Advanced Research Company's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 264.58 (+16.72%) | Price Action: Chart |
| 2024 Target 2 | 259.65 (+14.55%) | Price Action: Aug 2023 High |
| 2024 Target 1 | 257.05 (+13.4%) | Price Action: Apr 2022 Low |
| Current Price | 226.66 | Sun Pharma Advanced Research Company's 1 share price as of Fri 26 Jul 2024 |
| Stop Loss 1 | 210.90 (-6.96%) | Price Action: Jan 2020 High |
| Stop Loss 2 | 207.50 (-8.46%) | Price Action: Feb 2020 High |
| Stop Loss 3 | 205.30 (-9.43%) | Fibonacci Retracement Level 98.6% |
Summary: Sun Pharma Advanced Research Company Share Price Prediction For 2024
In summary, Sun Pharma Advanced Research Company has declined by ₹-60.14, recording a notable -20.97% decrease from 1st January 2024 to 26 Jul 2024. Despite the setback, our analysis of Sun Pharma Advanced Research Company for 2024 predicts an additional rise of 13.4% to 16.72% by the end of 2024 with three potential targets T1: 257.05, T2: 259.65, T3: 264.58. Stop Loss at SL1: 210.90, SL2: 207.50, SL3: 205.30.
Sun Pharma Advanced Research Company has a 52-week high of ₹472.79, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹196.10, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Sun Pharma Advanced Research Company.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Sun Pharma Advanced Research Company Share Price Target For 2025
The line chart displays the monthly closing prices of Sun Pharma Advanced Research Company with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Sun Pharma Advanced Research Company shares in 2025, see the table below.
Advertisement
Sun Pharma Advanced Research Company Share Price Target Table For 2025
| Sun Pharma Advanced Research Company's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 407.77 (+79.9%) | Price Action: Chart |
| 2025 Target 2 | 400.17 (+76.55%) | Price Action: Chart |
| 2025 Target 1 | 396.21 (+74.8%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 226.66 | Sun Pharma Advanced Research Company's 1 share price as of Fri 26 Jul 2024 |
| Stop Loss 1 | 185.37 (-18.22%) | Price Action: Chart |
| Stop Loss 2 | 183.52 (-19.04%) | Price Action: Chart |
| Stop Loss 3 | 180.22 (-20.49%) | Price Action: Chart |
Summary: Sun Pharma Advanced Research Company Share Price Prediction For 2025
In summary, Sun Pharma Advanced Research Company has declined by ₹-60.14, recording a notable -20.97% decrease from 1st January 2024 to 26 Jul 2024. Despite the setback, our analysis of Sun Pharma Advanced Research Company for 2025 predicts an additional rise of 74.8% to 79.9% by the end of 2025 with three potential targets T1: 396.21, T2: 400.17, T3: 407.77. Stop Loss at SL1: 185.37, SL2: 183.52, SL3: 180.22.
Sun Pharma Advanced Research Company has a All-Time high of ₹593.95, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹196.10, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Sun Pharma Advanced Research Company, we have created a specific page for that check here: Sun Pharma Advanced Research Company Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Sun Pharma Advanced Research Company Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Sun Pharma Advanced Research Company share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 1.43% over the next 15 years.
For complete year by year Sun Pharma Advanced Research Company long term share price target from 2024, 2025 to 2039 check the below table.
Sun Pharma Advanced Research Company Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Sun Pharma Advanced Research Company Target | YoY Change % |
|---|---|---|
| 2024 | ₹226.66 | [Current Price] |
| 2024 | ₹234.61 | 3.5% |
| 2025 | ₹212.21 | -9.55% |
| 2026 | ₹192.48 | -9.3% |
| 2027 | ₹166.01 | -13.76% |
| 2028 | ₹158.84 | -4.32% |
| 2029 | ₹168.63 | 6.16% |
| 2030 | ₹203.16 | 20.47% |
| 2031 | ₹199.81 | -1.65% |
| 2032 | ₹183.39 | -8.22% |
| 2033 | ₹192.26 | 4.83% |
| 2034 | ₹273.87 | 42.44% |
| 2035 | ₹273.67 | -0.08% |
| 2036 | ₹283.8 | 3.7% |
| 2037 | ₹270.13 | -4.82% |
| 2038 | ₹296.93 | 9.92% |
| 2039 | ₹286.2 | -3.62% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Sun Pharma Advanced Research Company Past Performance
- In 2007, Sun Pharma Advanced Research Company opening price was ₹90.86
- As of Fri 26 Jul 2024 the price stands at ₹226.66.
- This represents a Compound Annual Growth Rate (CAGR) of 5.21%.
- In 17 years, an investment of 10,000 would have become ₹24,946.07.
As we wrap up, we hope you like our study on Sun Pharma Advanced Research Company share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Sun Pharma Advanced Research Company Share Price History
- Sun Pharma Advanced Research Company Price Target Tomorrow
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
